812
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Do marine algal polyphenols have antidiabetic, antihyperlipidemic or anti-inflammatory effects in humans? A systematic review

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abu-Ghannam, N. and Cox, S. (2014). Seaweed-based functional foods. In: Bioactive Compounds from Marine Foods: Plant and Animal Sources. B. Hernandez-Ledesma and M. Herrero, Eds. Madrid, Spain: Wiley-Blackwell.
  • Academy of Nutrition and Dietetics (2012).Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process. Chicago, IL, USA: ADA Research and Strategic Business Development.
  • Almoosawi, S., Fyfe, L., Ho, C. and Al-Dujaili, E. (2010). The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br. J. Nutr. 103(6):842–850.
  • Anderson, J. W., Vichitbandra, S., Qiun, W. and Kryscio, R. J. (1999). Long-term weight maintenance after an intensive weight-loss program. J. Am. Coll. Nutr. 18(6):620–627.
  • Apostolidis, E. and Lee, C. (2010). In vitro potential of ascophyllum nodosum phenolic antioxidant-mediated α-glucosidase and α-amylase inhibition. J. Food Sci. 75(3):H97–H102.
  • Bahadoran, Z., Mirmiran, P. and Azizi, F. (2013). Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J. Diabetes Metab. Disord. 12(43):1–9.
  • Blandon, J., Cranfield, J. and Henson, S. (2007). Functional Food and Natural Health Product Issues: The Canadian and International Context Department of Food Agricultural and Resource Economics. International Food Economy Research Group, Canada.
  • Bocanegra, A., Bastida, S., Benedí, J., Ródenas, S. and Sánchez-Muniz, F. J. (2009). Characteristics and nutritional and cardiovascular-health properties of seaweeds. J. Med. Food 12(2):236–258.
  • Choi, E.-K., Park, S.-H., Ha, K.-C., Noh, S.-O., Jung, S.-J., Chae, H.-J., Chae, S.-W. and Park, T.-S. (2015). Clinical trial of the hypolipidemic effects of a brown alga Ecklonia cava extract in patients with hypercholesterolemia. Int. J. Pharm. 11(7):798–805.
  • Christiansen, T., Bruun, J. M., Madsen, E. L. and Richelsen, B. (2007). Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow up. Obesity 15(2):413–420.
  • Diabetes Australia. (2009). Pre-diabetes. Available from https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/f3652e02-a3fc-4c59-b2f1-5a22ba829547.pdf [Accessed January 18, 2017].
  • Dietitians Associaiton of Australia (2006). Evidence Based Practice Guidelines for the Nutritional Management of Type 2 Diabetes Mellitus for Adults. Dietitians Association of Australia, New South Wales.
  • Elmarakby, A. A., Abdelsayed, R., Liu, J. Y. and Mozaffari, M. S. (2010). Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J. 1:117–129.
  • Eo, H., Jeon, Y.-J., Lee, M. and Lim, Y. (2015). Brown alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet-induced obese mice. J. Agric. Food Chem. 63:349–359.
  • Greenberg, A. S. and Obin, M. S. (2006). Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 83(suppl):461S–465S.
  • Hamed, I., Ozogul, F., Ozogul, Y. and Regenstein, J. M. (2015). Marine bioactive compounds and their health benefits: A review. Compr. Rev. Food Sci. Food Saf. 14:446–465.
  • Heffernan, N., Brunton, N. P., FitzGerald, R. J. and Smyth, T. J. (2015). Profiling of the molecular weight and structural isomer abundance of macroalgae-derived phlorotannins. Marine Drugs 13:509–528.
  • Heo, S.-J., Hwang, J.-Y., Choi, J.-I., Han, J.-S., Kim, H.-J. and Jeon, Y.-J. (2009). Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent α-glucosidase and α-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 615:252–256.
  • Hernandez-Corona, D. M., Martınez-Abundis, E. and Gonzalez-Ortiz, M. (2014). Effect of fucoidan administration on insulin secretion and insulin resistance in overweight or obese adults. J. Med. Food 17(7):830–832.
  • Higdon, J. V. and Frei, B. (2003). Tea catechins and polyphenols: Health effects, metabolism an antioxidant functions. Crit. Rev. Food Sci. Nutr. 43(1):89–143.
  • Hursel, R., Viechtbauer, W. and Westerterp-Plantenga, M. (2009). The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int. J. Obes. 33:956–961.
  • Iwai, K. (2008). Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-Ay mice. Plant Foods Hum. Nutr. 63:163–169.
  • Jeffery, R. W., Epstein, L. H., Wilson, G. T., Drewnowski, A., Stunkard, A. J., Wing, R. R. and Hill, D. R. (2000). Long-term maintenance of weight loss: current status. Health Psychol. 19(1(Suppl):5–16.
  • Jialal, I. and Devaraj, S. (2014). Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes Care 37:e106–e107.
  • Jung, H. A., Yoon, N. Y., Woo, M.-H. and Choi, J. S. (2008). Inhibitory activities of extracts from several kinds of seaweeds and phlorotannins from the brown alga Ecklonia stolonifera on glucose-mediated protein damage and rat lens aldose reductase. Fish Sci. 74:1363–1365.
  • Kang, C., Jin, Y. B., Lee, H., Cha, M., Sohn, E.-t., Moon, J., Park, C., Chun, S., Jung, E.-S., Hong, J.-S., Kim, S. B., Kim, J.-S. and Kim, E. (2010). Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem. Toxicol. 48:509–516.
  • Kang, M.-C., Wijesinghe, W., Lee, S.-H., Kang, S.-M., Ko, S.-C., Yang, X., Kang, N., Jeon, B.-T., Kim, J., Lee, D.-H. and Jeon, Y.-J. (2013). Dieckol isolated from brown seaweed Ecklonia cava attenuates type II diabetes in db/db mouse model. Food Chem. Toxicol. 53:294–298.
  • Kang, N.-J., Han, S.-C., Kang, G.-J., Koo, D.-H., Koh, Y.-S., Hyun, J.-W., Lee, N. H., Ko, M.-H., Kang, H.-K. and Yoo, E.-S. (2015). Diphlorethohydroxycarmalol inhibits interleukin-6 production by regulating NF-κB, STAT5 and SOCS1 in lipopolysaccharide-stimulated RAW264.7 cells. Mar. Drugs 13:2141–2157.
  • Kellogg, J., Esposito, D., Grace, M. H., Komarnytsky, S. and Lila, M. A. (2015). Alaskan seaweeds lower inflammation in RAW 264.7 macrophages and decrease lipid accumulation in 3T3-L1 adipocytes. J. Funct. Foods 15:396–407.
  • Kim, A.-R., Shin, T.-S., Lee, M.-S., Park, J.-Y., Park, K.-E., Yoon, N. Y., Kim, J.-S., Choi, J. S., Jang, B.-C., Byun, D.-S., Park, N.-K. and Kim, H.-R. (2009). Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and anti-inflammatory properties. J. Agric. Food Chem. 57:3483–3489.
  • Kim, S.-K. (2013).Marine Nutraceuticals: Prospects and Perspectives. Florida: CRC Press.
  • Lang, A. and Froelicher, E. S. (2006). Management of overweight and obesity in adults: Behavioral intervention for long-term weight loss and maintenance. Eur. J. Cardiovasc. Nurs. 5:102–114.
  • Lee, S.-H., Han, J.-S., Heo, S.-J., Hwang, J.-Y. and Jeon, Y.-J. (2010). Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. Toxicol. In Vitro 24:375–381.
  • Lee, S.-H. and Jeon, Y.-J. (2013). Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms. Fitoterapia 86:129–136.
  • Lee, S.-H. and Jeon, Y.-J. (2015). Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: A double-blind, randomized, placebo-controlled clinical trial. Food Funct. 6:853–858.
  • Lee, S.-H., Min, K.-H., Han, J.-S., Lee, D.-H., Park, D.-B., Jung, W.-K., Park, P.-J., Jeon, B.-T., Kim, S.-K. and Jeon, Y.-J. (2012). Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus. Food Chem. Toxicol. 50:575–582.
  • Lee, S.-H., Yong-Li, Karadeniz, F., Kimc, M.-M. and Kim, S.-K. (2009). α-Glucosidase and α-amylase inhibitory activities of phloroglucinal derivatives from edible marine brown alga, Ecklonia cava. J. Sci. Food Agric. 89:1552–1558.
  • Libby, P. (2006). Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 83(suppl):456S–460S.
  • Malik, P. and Mukherjee, T. K. (2014). Structure-function elucidation of antioxidative and prooxidative activities of the polyphenolic compound curcumin. Chinese J. Biol. 2014:8.
  • McGuire, M., Wing, R. and Hill, J. (1999). The prevalence of weight loss maintenance among American adults. Int. J. Obes. Relat. Metab. Disord. 23(12):1314–1319.
  • Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A. and Group, P.-P. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4(1).
  • Mordor Intelligence (2016). Global Nutraceuticals Market-Growth, Trends and Forecasts (2016–2021). USA: Research and Markets. 2016 November 2016 [cited 2016; Available from: http://www.researchandmarkets.com/reports/3957928/global-nutraceuticals-market-growth-trends-and#pos-8.]
  • Mouritsen, O. G., Dawezynski, C., Duelund, L., Jahreis, G., Vetter, W. and Schroder, M. (2013). On the human consumption of the red seaweed dulse (Palmaria palmata (L.) Weber & Mohr). J. Appl. Phycol. 25.
  • Murray, M., Dordevic, A. L., Ryan, L. and Bonham, M. P. (2016). An emerging trend in functional foods for the prevention of cardiovascular disease and diabetes: Marine algal polyphenols. Crit. Rev. Food. Sci. Nutr. ( Epub ahead of print). doi.org/10.1080/10408398.2016.1259209
  • Murugan, A. C., Karim, R., Yusoff, M. B. M., Tan, S. H., Asras, M. F. B. F. and Rashid, S. S. (2015). New insights into seaweed polyphenols on glucose homeostasis. Pharm. Biol. 53(8):1087–1097.
  • National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (2012). Reducing Risk in Heart Disease: An Expert Guide to Clinical Practice for Secondary Prevention of Coronary Heart Disease. Melbourne, Australia: National Heart Foundation of Australia.
  • National Institutes of Health (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, National Institutes of Health. Publication No. 98–4083. Available at URL: https://www.ncbi.nlm.nih.gov/books/NBK2003/pdf/Bookshelf_NBK2003.pdf
  • National Institutes of Health (2013). Managing Overweight and Obesity in Adults: Systematic Evidence Review From the Obesity Expert Panel, 2013, U.S. Department of Health and Human Services. Available at URL: https://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/obesity-evidence-review.pdf
  • Nwosu, F., Morris, J., Lund, V. A., Stewart, D., Ross, H. A. and McDougall, G. J. (2011). Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae. Food Chem. 126:1006–1012.
  • Nyambe-Silavwe, H. and Williamson, G. (2016). Polyphenol- and fibre-rich dried fruits with green tea attenuate starch-derived postprandial blood glucose and insulin: a randomised, controlled, single-blind, cross-over intervention. Br. J. Nutr. 116:443–450.
  • O'Keefe, J. H. and Bell, D. S. (2007). Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am. J. Cardiol. 100:899–904.
  • Okada, Y., Ishimaru, A., Suzuki, R. and Okuyama, T. (2004). A new phloroglucinol derivative from the brown alga Eisenia bicyclis: Potential for the effective treatment of diabetic complications. J. Nat. Prod. 67:103–105.
  • Osiecki, H. (2004). The role of chronic inflammation in cardiovascular disease and its regulation by nutrients. Altern. Med. Rev. 9(1):32–53.
  • Paradis, M.-E., Couture, P. and Lamarche, B. (2011). A randomised crossover placebo-controlled trial investigating the effect of brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) on postchallenge plasma glucose and insulin levels in men and women. Appl. Physiol. Nutr. Metab. 36:913–919.
  • Park, E. Y., Kim, E. H., Kim, M. H., Seo, Y. W., Lee, J. I. and Jun, H. S. (2012). Polyphenol-rich fraction of brown alga Ecklonia cava collected from Gijang, Korea, reduces obesity and glucose levels in high-fat diet-induced obese mice. Evid. Based Complement Alternat. Med. 2012:1–11.
  • Rains, T. M., Agarwal, S. and Maki, K. C. (2011). Antiobesity effects of green tea catechins: A mechanistic review. J. Nutr. Biochem. 22:1–7.
  • Ridker, P. M., Hennekens, C. H., Buring, J. E. and Rifai, N. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl. J. Med. 342:836–843.
  • Roy, M. S., Janal, M. N., Crosby, J. and Donnelly, R. (2013). Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol. Vis. Sci. 54:5471–5480.
  • Roy, M. S., Janal, M. N., Crosby, J. and Donnelly, R. (2015). Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes. Kidney Int. 87:427–433.
  • Shin, H. C., Kim, S. H., Park, Y., Lee, B. H. and Hwang, H. J. (2012). Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: A double-blind randomized clinical trial. Phytother. Res. 26(3):363–368.
  • Tsao, R. (2010). Chemistry and biochemistry of dietary polyphenols. Nutrients 2:1231–1246.
  • Wellen, K. E. and Hotamisligil, G. S. (2005). Inflammation, stress and diabetes. J. Clin. Invest. 115(5):1111–1119.
  • Wijesekara, I., Yoon, N. Y. and Kim, S.-K. (2010). Phlorotannins from Ecklonia cava (Phaeophyceae): Biological activities and potential health benefits. BioFactors 36(6):408–414.
  • Willerson, J. T. and Ridker, P. M. (2004). Inflammation as a Cardiovascular Risk Factor. Circulation 109(suppl II):II-2–II-10.
  • Wing, R. R. and Phelan, S. (2005). Long-term weight loss maintenance. Am. J. Clin. Nutr. 82(suppl):222S–225S.
  • World Health Organization. (2015a, January 2015). Obesity and Overweight Fact Sheet No. 311. Available from http://www.who.int/mediacentre/factsheets/fs311/en/ [Accessed July 14, 2015].
  • World Health Organization. (2015b, September 2016). Cardiovascular Diseases (CVDs) Fact Sheet No. 317. Available from http://www.who.int/mediacentre/factsheets/fs317/en/ [Accessed September 2016].
  • World Health Organization. (2015c, June 2016). Diabetes Fact Sheet No. 312. Available from http://www.who.int/mediacentre/factsheets/fs312/en/ [Accessed September 2016].
  • Yang, E.-J., Moon, J.-Y., Kim, S. S., Yang, K.-W., Lee, W. J., Lee, N. H. and Hyun, C.-G. (2014). Jeju seaweeds suppress lipopolysaccharide-stimulated proinflammatory response in RAW 264.7 murine macrophages. Asian Pac. J. Trop. Biomed. 4(7):529–537.
  • Yeo, A.-R., Lee, J., Tae, I. H., Park, S.-R., Cho, Y. H., Lee, B. H., Shin, H. C., Kim, S. H. and Yoo, Y. C. (2012). Anti-hyperlipidemic effect of polyphenol extract (Seapolynol™) and dieckol isolated from Ecklonia cava in in vivo and in vitro models. Prev. Nutr. Food Sci. 17:1–7.
  • Yoon, N. Y., Kim, H. R., Chung, H. Y. and Choi, J. S. (2008). Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch. Pharm. Res. 31(12):1564–1571.
  • Zhang, J., Tiller, C., Shen, J., Wang, C., Girouard, G. S., Dennis, D., Barrow, C. J., Miao, M. and Ewart, H. S. (2007). Antidiabetic properties of polysaccharide- and polyphenolic-enriched fractions from the brown seaweed Ascophyllum nodosum. Can. J. Physiol. Pharmacol. 85:1116–1123.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.